Opill: payments to doctors
Payments that named Opill as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1M
- Providers
- 10
- Transactions
- 32
- Average per transaction
- $32,054
The per-transaction average — $32,054 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10 providers the average total is $102,572, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| HRA Pharma | $954,396 | 93.0% |
| Perrigo Company PLC | $71,329 | 7.0% |